secwatch.observer — SEC 8-K summary
======================================

Issuer:     LISATA THERAPEUTICS, INC. (LSTA)
CIK:        0000320017
Form:       8-K
Filed at:   2026-05-04T23:59:59+00:00
Accession:  0001140361-26-018651
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lisata extends tender offer deadline to May 29; Kuva to pay up to $1.1M in expenses
--------------------------------------------------------------------------------

- Tender offer commencement extended from April 13 to May 29, 2026, under amended merger agreement.
- Kuva Labs to pay Lisata up to $1.1M via five interim payments: $175k on May 5, $175k on May 7, $250k on May 12, $250k on May 19, $250k on May 26.
- Lisata agrees not to sue Kuva until May 29; waives all claims for failure to start offer by April 13 upon commencement and payment of interim amounts.
- Waiver terminates if Kuva fails to make any interim payment when due or commits an uncured material breach.
- Original merger agreement signed March 6, 2026; deal remains subject to regulatory and stockholder conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/320017/000114036126018651/0001140361-26-018651-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/320017/000114036126018651/ef20072320_form8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-018651

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer